Clinical Trial Update: Dietary Nitrate and Nitrite to Increase Nitric Oxide in Patients With Coronary Artery Disease [Phase 2]

View source ↗

Summary

NHLBI-sponsored Phase 2 trial evaluating dietary nitrate and nitrite to increase nitric oxide in patients with coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Coronary Arteriosclerosis | Phase 2 | Status: COMPLETED